Clinical Trial Update: A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS) [Phase 2]

View source ↗

Summary

Phase 2 study to determine the correct inhaled dose of Amikacin delivered directly to the lungs via the Pulmonary Delivery Device System (PDDS) in ventilated pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: Bayer | Conditions: Pneumonia | Phase 2 | Status: COMPLETED